Nancy D. Ebelt
- Molecular Biology
- Oncology top 10%
- Immunology top 10%
- Cancer Research
- Biomedical Engineering
- Co-authors
- Edwin R. ManuelMonica MarzagalliCarla L. Van Den BergM. A. CantrellTravis H. StrackerBlerta XhemalçeKyle M. MillerKevin N. Dalby
- Topics
- Melanoma and MAPK Pathways (6 papers)Cancer Research and Treatments (5 papers)Cancer Cells and Metastasis (4 papers)
- Cited by
- OncologyImmunologyBiotechnology
- Partner nations
- United StatesEgyptSaudi Arabia
In The Last Decade
Nancy D. Ebelt
21 papers receiving 760 citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 386
- Oncology 335
- Immunology 219
- Cancer Research 91
- Biomedical Engineering 90
Countries citing papers authored by Nancy D. Ebelt
This map shows the geographic impact of Nancy D. Ebelt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy D. Ebelt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy D. Ebelt more than expected).
Fields of papers citing papers by Nancy D. Ebelt
This network shows the impact of papers produced by Nancy D. Ebelt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy D. Ebelt. The network helps show where Nancy D. Ebelt may publish in the future.
Co-authorship network of co-authors of Nancy D. Ebelt
This figure shows the co-authorship network connecting the top 25 collaborators of Nancy D. Ebelt. A scholar is included among the top collaborators of Nancy D. Ebelt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy D. Ebelt. Nancy D. Ebelt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 5 | |
| 3 | 0 | |
| 4 | 20 | |
| 5 | 18 | |
| 6 | 66 | |
| 7 | 17 | |
| 8 | 19 | |
| 9 | 42 | |
| 10 | 20 | |
| 11 | 267 | |
| 12 | 6 | |
| 13 | 23 | |
| 14 | 30 | |
| 15 | 50 | |
| 16 | 1 | |
| 17 | 61 | |
| 18 | 55 | |
| 19 | 40 | |
| 20 | 22 |
About Nancy D. Ebelt
Nancy D. Ebelt is a scholar working on Biotechnology, Oncology and Biological Psychiatry, having authored 22 papers that have together received 773 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (6 papers), Cancer Research and Treatments (5 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Oncology (335 citations), Immunology (219 citations) and Biotechnology (56 citations). Nancy D. Ebelt has collaborated with scholars based in United States, Egypt and Saudi Arabia. Frequent co-authors include Edwin R. Manuel, Monica Marzagalli, Carla L. Van Den Berg, M. A. Cantrell, Travis H. Stracker, Blerta Xhemalçe, Kyle M. Miller, Kevin N. Dalby, Ramakrishna Edupuganti and Tamer S. Kaoud. Their work appears in journals such as Nature Communications, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.